Le diagnostic se fait par l'examen des selles pour détecter les oocystes d'Isospora.
IsosporiasisDiagnostic médical
#2
Quels tests sont utilisés pour l'isosporidiose ?
Des tests de laboratoire, comme la microscopie des selles, sont utilisés pour identifier le parasite.
IsosporiasisTests de laboratoire
#3
Les symptômes aident-ils au diagnostic ?
Oui, les symptômes cliniques comme la diarrhée aiguë orientent vers le diagnostic.
SymptômesIsosporiasis
#4
L'imagerie est-elle utile pour le diagnostic ?
L'imagerie n'est généralement pas utilisée pour diagnostiquer l'isosporidiose.
Imagerie médicaleIsosporiasis
#5
Peut-on diagnostiquer par biopsie ?
La biopsie intestinale est rare mais peut être utilisée dans des cas complexes.
BiopsieIsosporiasis
Symptômes
5
#1
Quels sont les symptômes de l'isosporidiose ?
Les symptômes incluent diarrhée, douleurs abdominales, nausées et perte de poids.
SymptômesIsosporiasis
#2
L'isosporidiose cause-t-elle de la fièvre ?
Oui, la fièvre peut être présente, surtout dans les cas sévères d'infection.
FièvreIsosporiasis
#3
Les symptômes varient-ils selon l'âge ?
Oui, les enfants et les immunodéprimés peuvent avoir des symptômes plus graves.
EnfantsIsosporiasis
#4
Peut-on avoir des symptômes asymptomatiques ?
Oui, certaines personnes peuvent être infectées sans présenter de symptômes.
AsymptomatiqueIsosporiasis
#5
Les symptômes persistent-ils longtemps ?
Sans traitement, les symptômes peuvent persister plusieurs semaines à mois.
Durée des symptômesIsosporiasis
Prévention
5
#1
Comment prévenir l'isosporidiose ?
La prévention passe par une bonne hygiène, notamment le lavage des mains et des aliments.
PréventionHygiène
#2
Les voyageurs doivent-ils se méfier ?
Oui, les voyageurs dans des zones à risque doivent être prudents avec l'eau et la nourriture.
VoyageIsosporiasis
#3
Les animaux peuvent-ils transmettre l'isosporidiose ?
Non, l'isosporidiose est principalement une infection humaine et ne se transmet pas par les animaux.
TransmissionIsosporiasis
#4
Le traitement préventif est-il recommandé ?
Un traitement préventif peut être recommandé pour les personnes immunodéprimées.
PréventionImmunodépression
#5
Les oocystes sont-ils résistants ?
Oui, les oocystes d'Isospora sont résistants et peuvent survivre dans l'environnement.
OocystesIsosporiasis
Traitements
5
#1
Quel est le traitement de l'isosporidiose ?
Le traitement principal est le triméthoprime-sulfaméthoxazole (TMP-SMX).
TraitementIsosporiasis
#2
Y a-t-il des traitements alternatifs ?
D'autres médicaments comme la nitazoxanide peuvent être utilisés dans certains cas.
MédicamentsIsosporiasis
#3
Le traitement est-il efficace ?
Oui, le traitement est généralement efficace, surtout s'il est administré tôt.
Efficacité du traitementIsosporiasis
#4
Combien de temps dure le traitement ?
Le traitement dure généralement 7 à 10 jours, selon la gravité de l'infection.
Durée du traitementIsosporiasis
#5
Des soins de soutien sont-ils nécessaires ?
Oui, une réhydratation et des soins de soutien peuvent être nécessaires en cas de déshydratation.
Soins de soutienIsosporiasis
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent la déshydratation sévère et des infections secondaires.
ComplicationsIsosporiasis
#2
L'isosporidiose peut-elle être mortelle ?
Dans les cas graves, surtout chez les immunodéprimés, elle peut être mortelle.
MortalitéIsosporiasis
#3
Y a-t-il des complications à long terme ?
Des complications à long terme comme le syndrome de malabsorption peuvent survenir.
Syndrome de malabsorptionIsosporiasis
#4
Les complications sont-elles fréquentes ?
Elles sont plus fréquentes chez les personnes immunodéprimées que chez les individus sains.
ImmunodépressionIsosporiasis
#5
Comment gérer les complications ?
La gestion des complications nécessite souvent une hospitalisation et des soins intensifs.
Gestion des complicationsIsosporiasis
Facteurs de risque
5
#1
Qui est à risque d'isosporidiose ?
Les personnes immunodéprimées, comme celles atteintes du VIH, sont à risque élevé.
Facteurs de risqueImmunodépression
#2
Les enfants sont-ils plus à risque ?
Oui, les jeunes enfants, surtout ceux en collectivité, sont plus à risque.
EnfantsIsosporiasis
#3
Le voyage augmente-t-il le risque ?
Oui, voyager dans des régions où l'isosporidiose est endémique augmente le risque d'infection.
VoyageIsosporiasis
#4
Les personnes âgées sont-elles à risque ?
Oui, les personnes âgées peuvent être plus vulnérables en raison d'un système immunitaire affaibli.
Personnes âgéesIsosporiasis
#5
Les conditions de vie influencent-elles le risque ?
Oui, les conditions de vie insalubres augmentent le risque d'exposition au parasite.
Conditions de vieIsosporiasis
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Isosporidiose : Questions médicales les plus fréquentes",
"headline": "Isosporidiose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Isosporidiose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-28",
"dateModified": "2025-03-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Isosporidiose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coccidiose",
"url": "https://questionsmedicales.fr/mesh/D003048",
"about": {
"@type": "MedicalCondition",
"name": "Coccidiose",
"code": {
"@type": "MedicalCode",
"code": "D003048",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.610.752.250"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Isosporidiose",
"alternateName": "Isosporiasis",
"code": {
"@type": "MedicalCode",
"code": "D021865",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Edmund J Flach",
"url": "https://questionsmedicales.fr/author/Edmund%20J%20Flach",
"affiliation": {
"@type": "Organization",
"name": "Wildlife Health Services, Zoological Society of London, Regents Park, London NW1 4RY, United Kingdom, edmund.flach@zsl.org."
}
},
{
"@type": "Person",
"name": "Hasita S Dodhia",
"url": "https://questionsmedicales.fr/author/Hasita%20S%20Dodhia",
"affiliation": {
"@type": "Organization",
"name": "Wildlife Health Services, Zoological Society of London, Regents Park, London NW1 4RY, United Kingdom."
}
},
{
"@type": "Person",
"name": "Amanda Guthrie",
"url": "https://questionsmedicales.fr/author/Amanda%20Guthrie",
"affiliation": {
"@type": "Organization",
"name": "Wildlife Health Services, Zoological Society of London, Regents Park, London NW1 4RY, United Kingdom."
}
},
{
"@type": "Person",
"name": "Damer P Blake",
"url": "https://questionsmedicales.fr/author/Damer%20P%20Blake",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathobiology and Population Sciences, Royal Veterinary College, Hatfield AL9 7TA, United Kingdom."
}
},
{
"@type": "Person",
"name": "Chloe Thabet",
"url": "https://questionsmedicales.fr/author/Chloe%20Thabet",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36100355",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/archdischild-2022-323807"
}
},
{
"@type": "ScholarlyArticle",
"name": "A case of intravenous iron administration resulting in cerebral edema expansion.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37254070",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-023-03258-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Feasibility of periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis.",
"datePublished": "2023-06-25",
"url": "https://questionsmedicales.fr/article/37392544",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejrad.2023.110949"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimization of intravenous administration of hydroxocobalamin in pediatric emergencies - HYDROX-OPTIMIS study.",
"datePublished": "2023-10-21",
"url": "https://questionsmedicales.fr/article/37871551",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ienj.2023.101353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers.",
"datePublished": "2023-02-09",
"url": "https://questionsmedicales.fr/article/36758192",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/OP.22.00421"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies parasitaires",
"item": "https://questionsmedicales.fr/mesh/D010272"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protozooses",
"item": "https://questionsmedicales.fr/mesh/D011528"
},
{
"@type": "ListItem",
"position": 5,
"name": "Coccidiose",
"item": "https://questionsmedicales.fr/mesh/D003048"
},
{
"@type": "ListItem",
"position": 6,
"name": "Isosporidiose",
"item": "https://questionsmedicales.fr/mesh/D021865"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Isosporidiose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Isosporidiose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Isosporidiose",
"description": "Comment diagnostiquer l'isosporidiose ?\nQuels tests sont utilisés pour l'isosporidiose ?\nLes symptômes aident-ils au diagnostic ?\nL'imagerie est-elle utile pour le diagnostic ?\nPeut-on diagnostiquer par biopsie ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Isosporidiose",
"description": "Quels sont les symptômes de l'isosporidiose ?\nL'isosporidiose cause-t-elle de la fièvre ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes asymptomatiques ?\nLes symptômes persistent-ils longtemps ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Isosporidiose",
"description": "Comment prévenir l'isosporidiose ?\nLes voyageurs doivent-ils se méfier ?\nLes animaux peuvent-ils transmettre l'isosporidiose ?\nLe traitement préventif est-il recommandé ?\nLes oocystes sont-ils résistants ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Isosporidiose",
"description": "Quel est le traitement de l'isosporidiose ?\nY a-t-il des traitements alternatifs ?\nLe traitement est-il efficace ?\nCombien de temps dure le traitement ?\nDes soins de soutien sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Isosporidiose",
"description": "Quelles complications peuvent survenir ?\nL'isosporidiose peut-elle être mortelle ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Isosporidiose",
"description": "Qui est à risque d'isosporidiose ?\nLes enfants sont-ils plus à risque ?\nLe voyage augmente-t-il le risque ?\nLes personnes âgées sont-elles à risque ?\nLes conditions de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D021865?mesh_terms=Administration,+Intravenous#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'isosporidiose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par l'examen des selles pour détecter les oocystes d'Isospora."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'isosporidiose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de laboratoire, comme la microscopie des selles, sont utilisés pour identifier le parasite."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques comme la diarrhée aiguë orientent vers le diagnostic."
}
},
{
"@type": "Question",
"name": "L'imagerie est-elle utile pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est généralement pas utilisée pour diagnostiquer l'isosporidiose."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par biopsie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie intestinale est rare mais peut être utilisée dans des cas complexes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'isosporidiose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée, douleurs abdominales, nausées et perte de poids."
}
},
{
"@type": "Question",
"name": "L'isosporidiose cause-t-elle de la fièvre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre peut être présente, surtout dans les cas sévères d'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les immunodéprimés peuvent avoir des symptômes plus graves."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes asymptomatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent être infectées sans présenter de symptômes."
}
},
{
"@type": "Question",
"name": "Les symptômes persistent-ils longtemps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, les symptômes peuvent persister plusieurs semaines à mois."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'isosporidiose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène, notamment le lavage des mains et des aliments."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se méfier ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs dans des zones à risque doivent être prudents avec l'eau et la nourriture."
}
},
{
"@type": "Question",
"name": "Les animaux peuvent-ils transmettre l'isosporidiose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'isosporidiose est principalement une infection humaine et ne se transmet pas par les animaux."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il recommandé ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement préventif peut être recommandé pour les personnes immunodéprimées."
}
},
{
"@type": "Question",
"name": "Les oocystes sont-ils résistants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les oocystes d'Isospora sont résistants et peuvent survivre dans l'environnement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de l'isosporidiose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est le triméthoprime-sulfaméthoxazole (TMP-SMX)."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres médicaments comme la nitazoxanide peuvent être utilisés dans certains cas."
}
},
{
"@type": "Question",
"name": "Le traitement est-il efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement efficace, surtout s'il est administré tôt."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement 7 à 10 jours, selon la gravité de l'infection."
}
},
{
"@type": "Question",
"name": "Des soins de soutien sont-ils nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une réhydratation et des soins de soutien peuvent être nécessaires en cas de déshydratation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la déshydratation sévère et des infections secondaires."
}
},
{
"@type": "Question",
"name": "L'isosporidiose peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, surtout chez les immunodéprimés, elle peut être mortelle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications à long terme comme le syndrome de malabsorption peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont plus fréquentes chez les personnes immunodéprimées que chez les individus sains."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite souvent une hospitalisation et des soins intensifs."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'isosporidiose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées, comme celles atteintes du VIH, sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants, surtout ceux en collectivité, sont plus à risque."
}
},
{
"@type": "Question",
"name": "Le voyage augmente-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions où l'isosporidiose est endémique augmente le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus vulnérables en raison d'un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les conditions de vie insalubres augmentent le risque d'exposition au parasite."
}
}
]
}
]
}
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
2020-12-31
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
2020-12-31
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
2020-12-31
Intranasal nalbuphine could be a safe, efficacious and non-invasive alternative to parenteral pain medication in infants. We aimed to assess pharmacokinetics (PK) and tolerability of intranasal and in...
Prospective open-label study including infants 1-3 months of age admitted to the emergency department, receiving nalbuphine for procedural pain management. Patients were alternately allocated to a sin...
Out of 52 study subjects receiving nalbuphine, 31 were eligible for NCA (11 intravenous, 20 intranasal). Median AUC...
This is the first study investigating intranasal administration of nalbuphine in infants suggesting an intranasal bioavailability close to 50%. Non-invasive intranasal application was well tolerated. ...
NCT03059511....
Iron plays an important role in the development of perihematomal edema (PHE) in the setting of intracerebral hemorrhage (ICH). Cerebral iron is increased via direct hemoglobin release in ICH, and seve...
A 46-year-old woman was admitted to the hospital with acute moderate-to-severe TBI. Her head computed tomography (CT) scan showed bifrontal hemorrhagic contusions with mild PHE. She was started on hyp...
We believe this is the first report of exacerbating PHE accompanied by clinical decline after intravenous iron administration in the setting of acute hemorrhagic brain contusions. Though the effects o...
To assess the feasibility of a periprocedural decision on the administration of intravenous contrast media in MRI for endometriosis and to evaluate the frequency and reasons of contrast administration...
In this retrospective, descriptive cross-sectional single-center study all patients were included, who received a pelvic MRI for evaluation of endometriosis between April 2021 and February 2023. Frequ...
303 consecutive patients (mean age, 33.4 years +/- 8.3 [standard deviation]) were evaluated. Periprocedural decision on the administration of intravenous contrast media had been made in all cases. For...
A periprocedural decision on the administration of contrast media in MRI for endometriosis is feasible with little effort. It allows the administration of contrast media to be avoided in most cases. I...
Procedures to prepare and infuse intravenous drugs are poorly documented....
To determinate the optimal mode of hydroxocobalamin administration in children in emergency care....
We identified three modes of administration: (1) connect infusion tubing to the vial, start the infusion and interrupt it when the desired dose has been delivered; (2) remove from the vial the volume ...
25 nurses performed each of these three procedures for children weighting 15 and 30 kg. Speed and precision were primary end-points; ease, safety and drug economy were secondary end-points....
Mode 3 was the fastest (42[37-61] sec) followed by modes 1 and 2 (p < 0.05). Mode 3 was the most precise (100[100-100]%) followed by modes 1 and 2 (p = 0.001). Mode 3 was the easiest (10.0[9.0-10.0]) ...
Taking the required volume from the vial and infuse directly was the fastest, the most precise, the easiest and most economical mode of administration. It should be recommended....
Median duration of daratumumab (DARA) administration for treatment of multiple myeloma is 3-7 hours for the intravenous formulation (DARA IV) and 3-5 minutes for the subcutaneous formulation (DARA SC)...
Time-based measurements were extracted using a scheduling/pharmacy software program that tracked patient movement through appointments for patients initiating DARA in Mayo Clinic infusion centers from...
Median total clinic times were 2.7-3.0 hours shorter for DARA SC versus DARA IV. Median clinic times were highest at dose 1 and decreased with subsequent doses. Median total chair times were 2.7-2.8 h...
Reduced clinic times were observed with DARA SC, indicating that use of DARA SC as a treatment option results in time savings that may free clinic resources. Furthermore, novel methods of electronic h...
Guidelines recommend an analgesia-first strategy for sedation during mechanical ventilation, but associations between opioids provided during mechanical ventilation and posthospitalization opioid-rela...
To evaluate associations between an intravenous opioid dose received during mechanical ventilation and postdischarge opioid-related outcomes in medical (nonsurgical) patients....
This retrospective cohort study evaluated adults receiving mechanical ventilation lasting 24 hours or more for acute respiratory failure and surviving hospitalization. Participants from 21 Kaiser Perm...
Terciles of median daily intravenous fentanyl equivalents during mechanical ventilation....
The primary outcome was the first filled opioid prescription in 1 year after discharge. Secondary outcomes included persistent opioid use and opioid-associated complications. Secondary analyses tested...
The study included 6746 patients across 21 hospitals (median age, 67 years [IQR, 57-76 years]; 53.0% male). Of the participants, 3114 (46.2%) filled an opioid prescription in the year prior to admissi...
In this retrospective cohort study of patients receiving mechanical ventilation, opioids administered during mechanical ventilation were associated with opioid prescriptions following hospital dischar...
Contrast-associated AKI may result in higher morbidity and mortality. Intravenous fluid administration remains the mainstay for prevention. There is a lack of consensus on the optimal administration s...
We conducted a secondary analysis of 4671 PRESERVE participants who underwent angiographic procedures. Although fluid type was randomized, strategy of administration was at the discretion of the clini...
The mean (SD) age was 70 (8) years, 94% of participants were male, and median (interquartile range) eGFR was 60 (41-60) ml/min per 1.73 m...
We found that administration of a total volume of 1000 ml, starting at least 1 hour before contrast injection and continuing postcontrast for a total of 6 hours, is associated with a similar risk of a...
The metabolism of lufotrelvir, a novel phosphate prodrug of PF-00835231 for the treatment of COVID-19, was evaluated in healthy human volunteers and clinical trial participants with COVID-19 following...
Vedolizumab is a humanized monoclonal antibody, indicated for the treatment of moderately to severely active ulcerative colitis (UC) or Crohn's disease (CD), that specifically binds to the α4β7 integr...
Sixteen participants received a single IV infusion of vedolizumab (300 mg). Blood samples were collected to measure vedolizumab serum concentrations. The safety of all subjects was monitored....
The pharmacokinetic analysis showed that vedolizumab reached the maximum observed serum concentration (C...
Vedolizumab was well tolerated in healthy Chinese subjects when administered as a single-dose IV 300 mg infusion. In this study, the rate of AVA positivity was 37.5%, which occurred near the end of th...
http://www.chinadrugtrials.org.cn : CTR20171528....
The benefits and risks of the intraosseous (IO) route for vascular access in patients with out-of-hospital cardiac arrest (OHCA) remain controversial. This study compares the success rates of establis...
This was a retrospective study conducted by the San-Min station of Taoyuan Fire Department. Data for IV access were collected between January 1, 2020, and December 31, 2020. Data for IO access were co...
A total of 112 adult patients were enrolled in the analysis, including 71 men and 41 women, with an average age of 67 years. There were 90 IV access cases and 22 IO access cases. The groups were compa...
The IO route was significantly associated with higher success rates of route establishment, epinephrine administration, and shorter time-to-epinephrine in the prehospital resuscitation of adult patien...
